Halozyme Therapeutics shares owned by Harvey Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Harvey Capital Management
from 13F filings
Historical chart of Harvey Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Harvey Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Harvey Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $8.9M | 185k | 47.81 |
| 2024-09-30 | $11M | 186k | 57.24 |
| 2024-06-30 | $9.7M | 186k | 52.36 |
| 2024-03-31 | $7.4M | 182k | 40.68 |
| 2023-12-31 | $5.9M | 160k | 36.96 |
| 2015-09-30 | $735k | 55k | 13.42 |
| 2015-06-30 | $1.2M | 55k | 22.08 |
| 2015-03-31 | $1.1M | 78k | 14.27 |
| 2014-12-31 | $760k | 79k | 9.64 |
| 2014-09-30 | $3.2M | 349k | 9.10 |
| 2014-06-30 | $3.9M | 395k | 9.88 |
| 2014-03-31 | $5.0M | 392k | 12.70 |
| 2013-12-31 | $239k | 16k | 14.94 |
| 2013-09-30 | $741k | 67k | 11.03 |